DR.Chip Biotechnology Incorporation announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was TWD 25.984 million compared to TWD 26.945 million a year ago. Operating loss was TWD 3.375 million compared to TWD 6.895 million a year ago. Net income was TWD 2.608 million compared to net loss of TWD 5.730 million a year ago. Basic earnings per share was TWD 0.05 compared to basic loss per share of TWD 0.12 a year ago. For the nine months, sales was TWD 77.629 million compared to TWD 39.925 million a year ago. Operating loss was TWD 13.617 million compared to TWD 19.520 million a year ago. Net loss was TWD 4.328 million compared to TWD 17.176 million a year ago. Basic loss per share was TWD 0.09 compared to TWD 0.38 a year ago.